The TAF3/SREBP2/cholesterol axis drives tumor progression in hepatocellular carcinoma.

Qiu J, Cao L, Li Y, Li Y, Yin Z, Kong D, Chen N, Wang Z

Open source

DOI
10.1007/s10238-026-02267-4
Published
2026 Jul 31
Container
Clinical and experimental medicine
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s10238-026-02267-4,
  title = {The TAF3/SREBP2/cholesterol axis drives tumor progression in hepatocellular carcinoma.},
  author = {Qiu J and Cao L and Li Y and Li Y and Yin Z and Kong D and Chen N and Wang Z},
  year = {2026},
  journal = {Clinical and experimental medicine},
  doi = {10.1007/s10238-026-02267-4},
  url = {https://doi.org/10.1007/s10238-026-02267-4}
}

RIS

TY  - JOUR
TI  - The TAF3/SREBP2/cholesterol axis drives tumor progression in hepatocellular carcinoma.
AU  - Qiu J
AU  - Cao L
AU  - Li Y
AU  - Li Y
AU  - Yin Z
AU  - Kong D
AU  - Chen N
AU  - Wang Z
PY  - 2026
JO  - Clinical and experimental medicine
DO  - 10.1007/s10238-026-02267-4
UR  - https://doi.org/10.1007/s10238-026-02267-4
ER  - 

APA

J, Q., L, C., Y, L., Y, L., Z, Y., D, K., N, C., & Z, W. (2026). The TAF3/SREBP2/cholesterol axis drives tumor progression in hepatocellular carcinoma.. Clinical and experimental medicine. https://doi.org/10.1007/s10238-026-02267-4

Source records